Our article on ‘Key points to succeed in Artificial Intelligence drug discovery projects’ has been published by De Gruyter.

Drug discovery and development is an expensive, complex, and time-consuming task. Recently, the development of artificial intelligence (AI) approaches to drug discovery, specifically de novo drug design through the use of deep generative models… 

Follow the link to read the full article.